LFMD Stock Analysis: Buy, Sell, or Hold?

LFMD - LifeMD, Inc. Common Stock

SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
$3.61
0.01 (0.28%) ▲
5d: -6.96%
30d: +24.05%
90d: +4.94%
HOLD
LOW Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 05, 2026

Get Alerted When LFMD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: LFMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$18.11
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$11.25
67.9% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.9x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: LFMD is currently trading at $3.61, which is considered fair relative to its 30-day fair value range of $2.88 to $4.06. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.1) compared to its historical average (20.9). Remarkably, the market is currently pricing in an annual earnings decline of 27.1% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, LFMD is in a strong downtrend. Immediate support is located at $3.49, while resistance sits at $4.42.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.88 (+173.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Fair Price Range $2.88 - $4.06
Company Quality Score 48/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 72.4%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 173.5% below Wall St target ($9.88)
  • CAUTION: Recommendation downgraded due to -7.0% 5-day decline

Fair Price Analysis

30-Day Fair Range $2.88 - $4.06
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $3.49
Resistance Level $4.42
Current Trend Strong Downtrend
Technical data as of Mar 31, 2026

Fundamental Context

Forward P/E (Next Year Est.) 8.11
Wall Street Target $9.88 (+173.5%)
Revenue Growth (YoY) -27.1%
Profit Margin 7.4%
Valuation Discount vs History -27.1% cheaper
PE vs Historical 8.1 vs 20.9 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -27.1% (market-implied from PE analysis)
1-Year Target $3.25 (-10%)
2-Year Target $2.92 (-19%)
3-Year Target $2.63 (-27%)
3-Yr Target (if PE normalizes) (PE: 8→21) $6.78 (+88%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.4, Growth: 217.9%) $33.57 (+830%)
Base: (SPY PE: 8.1, Growth: 217.9%) $12.18 (+238%)
Bear: (PE: 6.9, Growth: 217.9%) $10.36 (+187%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.1 to 20.9
Stabilization Target: $9.30 (+157.6%)
PE Expansion Potential: +157.6%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: April 01, 2026 5:10 AM ET
Data refreshes hourly during market hours. Next update: 6:10 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jessica Friedeman SELL 15000 shares 2025-12-09

Unlock Insider Activity

See real-time buying/selling by company executives for LFMD.

Create Free Account

Already have an account? Log In

Top Rated Health Information Services Stocks

Top-rated stocks in Health Information Services by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VEEV
Veeva Systems Inc Class A
BUY
32 analysts
$271 54 HOLD
PRVA
Privia Health Group Inc
STRONG BUY
21 analysts
$32 52 HOLD
GEHC
GE HealthCare Technologi…
STRONG BUY
21 analysts
$90 58 HOLD
HQY
HealthEquity Inc
STRONG BUY
14 analysts
$112 66 BUY
PHR
Phreesia Inc
STRONG BUY
15 analysts
$28 51 HOLD

More Analysis for LFMD

LFMD Technical Chart LFMD Price Prediction LFMD Earnings Date LFMD Investment Advisor LFMD Fair Price Analyzer LFMD Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals